Interface - A New Series from NEJM Evidence.

Area of Science:

• Clinical research methodology
• Evidence-based medicine
• Translational science

Background:

• The NEJM Evidence series, Interface, focuses on study design.
• Understanding study design is crucial for clinical practice.
• Maximizing clinical utility should guide study design.

Discussion:

• Traditional randomized controlled trials (RCTs) and P-value interpretation have limitations.
• Binary interpretation of P values may not be optimal for clinical utility.
• Nuances in study design and execution impact the applicability of results.

Key Insights:

• Study design directly influences the clinical utility of research findings.
• A deeper understanding of methodology enhances evidence assessment.
• Moving beyond P-value reliance is essential for robust clinical decision-making.

Outlook:

• Future research will likely prioritize designs that enhance clinical applicability.
• The Interface series aims to foster critical appraisal of study methodologies.
• Advancements in study design will improve the translation of research into practice.